Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case study in an industrial setting

Roden DM (1993) Torsade de pointes. Clin Cardiol 16(9):683–686. https://doi.org/10.1002/clc.4960160910 Warmke JW, Ganetzky B (1994) A family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci 91(8):3438–3442. https://doi.org/10.1073/pnas.91.8.3438 Kaplan WD, Trout WE (1969) The behavior of four neurological mutants of Drosophila. Genetics 61(2):399–409 Sanguinetti MC, Tristani-Firouzi M (2006) HERG potassium channels and cardiac arrhythmia. Nature 440:463–469 Rampe D, Roy M-L, Dennis A, Brown AM (1997) A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG. FEBS Lett 417:28–32. https://doi.org/10.1016/S0014-5793(97)01249-0 Roy M-L, Dumaine R, Brown AM (1996) HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. Circulation 94(4):817. https://doi.org/10.1161/01.CIR.94.4.817 Priest B, Bell IM, Garcia M (2008) Role of HERG potassium channel assays in drug development. Channels 2(2):87–93. https://doi.org/10.4161/chan.2.2.6004 Cavalli A, Poluzzi E, De Ponti F, Recanatini M (2002) Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K+ channel blockers. J Med Chem 45(18):3844–3853. https://doi.org/10.1021/jm0208875 Aronov AM (2005) Predictive in silico modeling for HERG channel blockers. Drug Discov Today 10(2):149–155. https://doi.org/10.1016/S1359-6446(04)03278-7 Wang S, Sun H, Liu H, Li D, Li Y, Hou T (2016) ADMET evaluation in drug discovery. 16. Predicting HERG blockers by combining multiple pharmacophores and machine learning approaches. Mol Pharm. https://doi.org/10.1021/acs.molpharmaceut.6b00471 Schyman P, Liu R, Wallqvist A (2016) General purpose 2D and 3D similarity approach to identify HERG blockers. J Chem Inf Model 56(1):213–222. https://doi.org/10.1021/acs.jcim.5b00616 Anwar-Mohamed A, Barakat K, Bhat R, Noskov S, Lorne Tyrrell D, Tuszynski J, Houghton M (2014) A human ether-á-go-go-related (HERG) ion channel atomistic model generated by long supercomputer molecular dynamics simulations and its use in predicting drug cardiotoxicity. Toxicol Lett 230:382–392. https://doi.org/10.1016/j.toxlet.2014.08.007 Czodrowski P (2013) HERG me out. J Chem Inf Model 53(9):2240–2251. https://doi.org/10.1021/ci400308z Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B et al (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40(D1):D1100–D1107. https://doi.org/10.1093/nar/gkr777 Li X, Zhang Y, Li H, Zhao Y (2017) Modeling of the HERG K+ channel blockage using online chemical database and modeling environment (OCHEM). Mol Inform. https://doi.org/10.1002/minf.201700074 Su B-H, Shen M, Esposito EX, Hopfinger AJ, Tseng YJ (2010) In silico binary classification QSAR models based on 4D-fingerprints and MOE descriptors for prediction of HERG blockage. J Chem Inf Model 50(7):1304–1318. https://doi.org/10.1021/ci100081j Senese CL, Duca J, Pan D, Hopfinger AJ, Tseng YJ (2004) 4D-fingerprints, universal QSAR and QSPR descriptors. J Chem Inf Comput Sci 44(5):1526–1539. https://doi.org/10.1021/ci049898s Gavaghan CL, Arnby CH, Blomberg N, Strandlund G, Boyer S (2007) Development, interpretation and temporal evaluation of a global QSAR of HERG electrophysiology screening data. J Comput Aided Mol Des 21(4):189–206. https://doi.org/10.1007/s10822-006-9095-6 Passini E, Britton OJ, Lu HR, Rohrbacher J, Hermans AN, Gallacher DJ, Greig RJH, Bueno-Orovio A, Rodriguez B (2017) Human in silico drug trials demonstrate higher accuracy than animal models in predicting clinical pro-arrhythmic cardiotoxicity. Front Physiol. https://doi.org/10.3389/fphys.2017.00668 Munawar S, Windley MJ, Tse EG, Todd MH, Hill AP, Vandenberg JI, Jabeen I (2018) Experimentally validated pharmacoinformatics approach to predict hERG inhibition potential of new chemical entities. Front Pharmacol. https://doi.org/10.3389/fphar.2018.01035 Chemi G, Gemma S, Campiani G, Brogi S, Butini S, Brindisi M (2017) Computational tool for fast in silico evaluation of HERG K+ channel affinity. Front Chem. https://doi.org/10.3389/fchem.2017.00007 Bashir Surfraz M, Fowkes A, Plante JP (2017) A semi-automated approach to create purposeful mechanistic datasets from heterogeneous data: data mining towards the in silico predictions for oestrogen receptor modulation and teratogenicity. Mol Inform. https://doi.org/10.1002/minf.201600154 Steinmetz FP, Mellor CL, Meinl T, Cronin MTD (2015) Screening chemicals for receptor-mediated toxicological and pharmacological endpoints: using public data to build screening tools within a KNIME workflow. Mol Inform 34(2–3):171–178. https://doi.org/10.1002/minf.201400188 Sato T, Yuki H, Ogura K, Honma T (2018) Construction of an integrated database for HERG blocking small molecules. PLoS ONE 13(7):e0199348. https://doi.org/10.1371/journal.pone.0199348 Klimisch H-J, Andreae M, Tillmann U (1997) A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regul Toxicol Pharmacol 25(1):1–5. https://doi.org/10.1006/rtph.1996.1076 Hanser T, Barber C, Rosser E, Vessey JD, Webb SJ, Werner S (2014) Self organising hypothesis networks: a new approach for representing and structuring SAR knowledge. J Cheminform 6(1):21. https://doi.org/10.1186/1758-2946-6-21 Derek Nexus, Lhasa Limited. https://www.lhasalimited.org/products/derek-nexus.htm Sheridan RP (2013) Time-split cross-validation as a method for estimating the goodness of prospective prediction. J Chem Inf Model 53(4):783–790. https://doi.org/10.1021/ci400084k Plante J, Werner S (2018) JPlogP: an improved LogP predictor trained using predicted data. J Cheminform. https://doi.org/10.1186/s13321-018-0316-5 Ghose AK, Crippen GM (1986) Atomic physicochemical parameters for three-dimensional structure—directed quantitative structure-activity relationships I. Partition coefficients as a measure of hydrophobicity. J Comput Chem 7(4):565–577. https://doi.org/10.1002/jcc.540070419 Landrum G (2006) RDKit: Open-Source Cheminformatics Polonchuk L (2012) Toward a new gold standard for early safety: automated temperature-controlled HERG test on the PatchLiner. Front Pharmacol 3:3. https://doi.org/10.3389/fphar.2012.00003 Fawcett T (2006) An introduction to ROC analysis. Pattern Recognit Lett 27(8):861–874. https://doi.org/10.1016/j.patrec.2005.10.010 Altman DG, Bland JM (1994) Statistics notes: diagnostic tests 2: predictive values. BMJ 309(6947):102. https://doi.org/10.1136/bmj.309.6947.102 Brodersen KH, Ong CS, Stephan KE, Buhmann JM (2010) The balanced accuracy and its posterior distribution. IEEE, pp 3121–3124. https://doi.org/10.1109/ICPR.2010.764 Matthews BW (1975) Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochim Biophys Acta BBA Protein Struct 405(2):442–451. https://doi.org/10.1016/0005-2795(75)90109-9 Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Meas 20(1):37–46. https://doi.org/10.1177/001316446002000104 Briggs K, Barber C, Cases M, Marc P, Steger-Hartmann T (2015) Value of shared preclinical safety studies—the ETOX database. Toxicol Rep 2:210–221. https://doi.org/10.1016/j.toxrep.2014.12.004 Merget B, Turk S, Eid S, Rippmann F, Fulle S (2017) Profiling prediction of kinase inhibitors: toward the virtual assay. J Med Chem 60(1):474–485. https://doi.org/10.1021/acs.jmedchem.6b01611 Food and Drug Administration (FDA) (2018) M7(R1) assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk guidance for industry, p 131. https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM347725.pdf Hanser T, Barber C, Marchaland JF, Werner S (2016) Applicability domain: towards a more formal definition. SAR QSAR Environ Res 27(11):865–881. https://doi.org/10.1080/1062936X.2016.1250229